Newsroom-Katalog
Zeit | STADA Arzneimittel AG: Meldungen vom 10.10.2024 |
---|---|
11:10 | Press Release: EMA accepts Marketing Authorization Applications for AVT03, a Proposed Denosumab Biosimilar |
Zeit | STADA Arzneimittel AG: Meldungen vom 10.10.2024 |
---|---|
11:10 | Press Release: EMA accepts Marketing Authorization Applications for AVT03, a Proposed Denosumab Biosimilar |